These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 21331558)

  • 21. Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis.
    Kearon C
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():296-300. PubMed ID: 19630820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
    Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Shi M; Thavorn K; Hutton B; Le Gal G; Rodger M; Fergusson D
    J Thromb Haemost; 2021 Nov; 19(11):2801-2813. PubMed ID: 34379859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism.
    Barco S; Corti M; Trinchero A; Picchi C; Ambaglio C; Konstantinides SV; Dentali F; Barone M
    J Thromb Haemost; 2017 Jul; 15(7):1436-1442. PubMed ID: 28439954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.
    Pinede L; Ninet J; Duhaut P; Chabaud S; Demolombe-Rague S; Durieu I; Nony P; Sanson C; Boissel JP;
    Circulation; 2001 May; 103(20):2453-60. PubMed ID: 11369685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.
    Siragusa S; Malato A; Saccullo G; Iorio A; Di Ianni M; Caracciolo C; Coco LL; Raso S; Santoro M; Guarneri FP; Tuttolomondo A; Pinto A; Pepe I; Casuccio A; Abbadessa V; Licata G; Battista Rini G; Mariani G; Di Fede G
    Am J Hematol; 2011 Nov; 86(11):914-7. PubMed ID: 21953853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.
    Franco L; Giustozzi M; Agnelli G; Becattini C
    J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.
    Douketis JD; Gu CS; Schulman S; Ghirarduzzi A; Pengo V; Prandoni P
    Ann Intern Med; 2007 Dec; 147(11):766-74. PubMed ID: 18056660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol.
    Khan F; Kimpton M; Tritschler T; Le Gal G; Hutton B; Fergusson DA; Rodger MA
    Syst Rev; 2019 Oct; 8(1):245. PubMed ID: 31661033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating patients with cancer and acute venous thromboembolism.
    Donadini MP; Squizzato A; Ageno W
    Expert Opin Pharmacother; 2016; 17(4):535-43. PubMed ID: 26606049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
    Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.
    Galanaud JP; Bosson JL; Genty C; Presles E; Cucherat M; Sevestre MA; Quere I; Decousus H; Leizorovicz A
    J Thromb Haemost; 2012 Jun; 10(6):1004-11. PubMed ID: 22429908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism.
    Tran HA; Gibbs H; Merriman E; Curnow JL; Young L; Bennett A; Tan CW; Chunilal SD; Ward CM; Baker R; Nandurkar H
    Med J Aust; 2019 Mar; 210(5):227-235. PubMed ID: 30739331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis.
    Hsu C; Brahmandam A; Brownson KE; Huynh N; Reynolds J; Lee AI; Fares WH; Ochoa Chaar CI
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):169-175.e4. PubMed ID: 30660579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
    Robertson L; Yeoh SE; Stansby G; Agarwal R
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment of venous thromboembolism.
    Kearon C; Kahn SR
    Blood; 2020 Jan; 135(5):317-325. PubMed ID: 31917402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
    Kirkilesis GI; Kakkos SK; Tsolakis IA
    Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study.
    Schellong S; Ageno W; Casella IB; Chee KH; Schulman S; Singer DE; Desch M; Tang W; Voccia I; Zint K; Goldhaber SZ
    Semin Thromb Hemost; 2022 Jun; 48(4):446-458. PubMed ID: 33971682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
    Rollins BM; Silva MA; Donovan JL; Kanaan AO
    Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.